Nektar Therapeutics | NKTR - Pre Tax Profit


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Nektar Therapeutics

Nektar Therapeutics reported $-137081000 in Pre-Tax Profit for its fiscal quarter ending in March of 2023.


Pre Tax Profit Change
Agios Pharmaceuticals AGIO:US USD -81018000 117.54M
Baxter International BAX:US USD 387M 147M
Bluebird Bio BLUE:US USD 21.24M 11.1M
Cara Therapeutics CARA:US USD -26665000 3.67M
Dr.Reddys Laboratories DRRD:IN INR 13.83B 2.68B
Eisai 4523:JP JPY 27.42B 17.97B
Esperion Therapeutics ESPR:US USD -61719000 6.23M
Exelixis EXEL:US USD 48.28M 79.7M
Halozyme Therapeutics HALO:US USD 52.24M 18.55M
Immunogen IMGN:US USD -41014000 16.78M
Ionis Pharmaceuticals IONS:US USD -113000000 81M
Karyopharm Therapeutics KPTI:US USD -34072000 4.36M
MacroGenics MGNX:US USD -38009000 50.81M
Merck & Co MRK:US USD 4.48B 411M
Mirati Therapeutics MRTX:US USD -184586000 17.63M
Nektar Therapeutics NKTR:US USD -137081000 80.54M
Neurocrine Biosciences NBIX:US USD -103300000 221.2M
Roche Holding ROG:VX 8.85B 3.26B
Sarepta Therapeutics SRPT:US USD -512710000 411.4M
Seattle Genetics SGEN:US USD -170113000 26.28M
Takeda 4502:JP JPY 47.92B 59.24B
Teva Pharmaceutical Industries Ltd TEVA:IT USD -258000000 842M
Xencor XNCR:US USD -60763000 48.31M